Imfinzi - Drug Insight Report, 2019-2021 - ResearchAndMarkets.com

DUBLIN--()--The "Imfinzi - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Imfinzi - Drug Insight, 2019 report provides comprehensive information of the drug, Imfinzi. It includes drugs overview, Imfinzi mechanism of action, clinical trials, regulatory milestones, deals & Imfinzi's partnerships. It further provides Imfinzi`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Imfinzi sales till 2021. The report also throws light on Imfinzi market competition and emerging therapies in the same space as Imfinzi. Imfinzi SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Imfinzi overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Imfinzi Patent information in United States (US) and Europe (EU) has been highlighted
  • Imfinzi API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Imfinzi sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Imfinzi operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Imfinzi SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Imfinzi
  • Access to Imfinzi API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Imfinzi patents for the major markets- US and EU
  • Understand current and future Imfinzi`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Imfinzi
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Imfinzi
  • Identify opportunities in the same area as with Imfinzi SWOT analysis

Key Topics Covered

1. Report Introduction

2. Imfinzi - Overview

  • Imfinzi Product Description
  • Imfinzi Route of Synthesis
  • Imfinzi Mechanism of Action
  • Imfinzi Pharmacology
  • Imfinzi Pharmacodynamics
  • Imfinzi Pharmacokinetics
  • Imfinzi Adverse Reactions
  • Imfinzi Clinical Trials
  • Imfinzi Regulatory Milestones
  • Imfinzi Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Imfinzi Global Sales Assessment

  • Imfinzi Sales Global(Historical)
  • Imfinzi Sales Global(Forecasted)

6. Imfinzi Patent Details

7. Imfinzi Market Competition

8. Imfinzi Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Imfinzi SWOT Analysis

List of Tables

Table 1: Imfinzi, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Imfinzi Product Details, United States

Table 8: Imfinzi Product Details, Europe

Table 9: Imfinzi, Historical Global Sales till 2017 (in million USD)

Table 10: Imfinzi, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Imfinzi

Table 12: Imfinzi Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Imfinzi

Figure 2: Imfinzi, Historical Global Sales till 2017 (in million USD)

Figure 3: Imfinzi, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Imfinzi

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/lonvnj

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900